The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 261 through 270 of 424 results (Download Results)

Show results per page

Investigating the Post-Acute Sequelae of SARS-CoV-2 Infections: a Patient Oriented Canadian COVID‑19 Emergency Department Rapid Response Network (CCEDRRN) Study

Archambault, Patrick | Université Laval | Operating Grant | $499,945

CIHR Quebec 2021

A cell-based assay to measure immune competence in SARS-CoV-2 infection and vaccination

De Serres, Sacha | Université Laval | Operating Grant | $246,164

CIHR Quebec 2021

From idea to reality: COVID‑19 Vaccination for Children and Youth

Maguire, Jonathon L | Unity Health Toronto | Operating Grant | $496,871

CIHR Ontario 2021

COVID-19 Variant Supplement – Host cellular protein substrates of SARS-CoV-2 proteases

Jan, Eric | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

Muticentre Assessment of Cardiovascular Hemodynamics and Autonomic Dysfunction with Long COVID

Raj, Satish R | The University of Calgary | Operating Grant | $277,613

CIHR Alberta 2021

COVID-19 Variant Network – Agent-based and multi-scale mathematical modelling of COVID‑19 for assessments of sustained transmission risk and effectiveness of countermeasures

Murty, Vijayakumar | University of Toronto | Operating Grant | $100,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals

Bell, John C | Ottawa Hospital Research Institute | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19

Ng, Kenneth K | The University of Calgary | Operating Grant | $50,000

CIHR Alberta 2021

Mitigating the Effects of Epidemic/Pandemic Outbreaks on Temporary Foreign Agricultural Workers and Farm Operations in British Columbia

Jardine, Cynthia | University of the Fraser Valley | Project Grant | $348,075

CIHR British Columbia 2021

COVID-19 Variant Network – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases

Strynadka, Natalie C | University of British Columbia | Operating Grant | $100,000

CIHR British Columbia 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

Investigating the Post-Acute Sequelae of SARS-CoV-2 Infections: a Patient Oriented Canadian COVID‑19 Emergency Department Rapid Response Network (CCEDRRN) Study

A cell-based assay to measure immune competence in SARS-CoV-2 infection and vaccination

From idea to reality: COVID‑19 Vaccination for Children and Youth

COVID-19 Variant Supplement – Host cellular protein substrates of SARS-CoV-2 proteases

Muticentre Assessment of Cardiovascular Hemodynamics and Autonomic Dysfunction with Long COVID

COVID-19 Variant Network – Agent-based and multi-scale mathematical modelling of COVID‑19 for assessments of sustained transmission risk and effectiveness of countermeasures

COVID-19 Variant Supplement – Development of Vaccines to Prevent SARS-CoV-2 Infection of High Risk Individuals

COVID-19 Variant Supplement – Design and evaluation of novel inhibitors targeting SARS-CoV-2 polymerase to create lead compounds to develop more effective treatments of COVID-19

Mitigating the Effects of Epidemic/Pandemic Outbreaks on Temporary Foreign Agricultural Workers and Farm Operations in British Columbia

COVID-19 Variant Network – Bespoke transition state analog inhibitors of SARS-CoV-2 3CL and PL proteases